• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用扩增产生限制性酶切位点分析对台湾中部重型β地中海贫血患者进行分子诊断。

Molecular diagnosis of patients with beta-thalassemia major in central Taiwan by amplified created restriction site analysis.

作者信息

Peng C T, Wu J Y, Tsai C H, Tsai F J, Chang J G

机构信息

Department of Pediatrics, China Medical College Hospital, Taichung, Taiwan.

出版信息

J Hum Genet. 1998;43(4):237-41. doi: 10.1007/s100380050080.

DOI:10.1007/s100380050080
PMID:9852674
Abstract

beta-Thalassemia, a hematologic disorder characterized by the deficiency or the absence of beta-globin production, is the most widespread inherited disorder in the world; it is also common in Taiwan. We studied 38 patients in central Taiwan with beta-thalassemia major, using amplified created restriction site analysis for detection. On analysis, six different point mutations were found among 76 chromosomes, of which 32 chromosomes (42.1%) had a C to T substitution at nucleotide 654, 30 (40%) had frameshift codons 41/42 with four nucleotides (TCTT) deletion, 7 (9.2%) had an A to T substitution at codon 17, 3 (3.9%) had frameshift codons 71/72 (insertion of A), 2 (2.6%) had an A to G substitution at position -28, and 2 (2.6%) had frame-shift codons 27/28 (insertion of C). The first two mutations accounted for 62 of the 76 beta-thalassemia mutations in this study. As to mutations in each individual with beta-thalassemia major, the incidence of compound heterozygotes of two different mutations was higher than that of homozygotes of a single mutation (60% vs 40%). Compound heterozygotes of C to T substitution at nucleotide 654 of IVS-2 and frameshift codons 41/42 with four-nucleotide deletion was the most common pattern of beta-thalassemia mutations in each individual (23.7%). Our results were unique compared with those from similar studies performed in southern China. Frequencies of beta-thalassemia mutations found in the current study were assessed and compared with frequencies found in previous studies conducted in northern and southern Taiwan.

摘要

β地中海贫血是一种以β珠蛋白生成缺乏或缺失为特征的血液系统疾病,是世界上最普遍的遗传性疾病;在台湾也很常见。我们对台湾中部38例重型β地中海贫血患者进行了研究,采用扩增产生的限制性酶切位点分析进行检测。分析发现,76条染色体中有6种不同的点突变,其中32条染色体(42.1%)在核苷酸654处发生C到T的替换,30条(40%)有移码密码子41/42,缺失四个核苷酸(TCTT),7条(9.2%)在密码子17处发生A到T的替换,3条(3.9%)有移码密码子71/72(插入A),2条(2.6%)在-28位发生A到G的替换,2条(2.6%)有移码密码子27/28(插入C)。前两种突变占本研究中76种β地中海贫血突变的62种。至于重型β地中海贫血患者个体中的突变情况,两种不同突变的复合杂合子发生率高于单一突变的纯合子(60%对40%)。IVS-2的核苷酸654处C到T替换与四个核苷酸缺失的移码密码子41/42的复合杂合子是每个个体中最常见的β地中海贫血突变模式(23.7%)。与在中国南方进行的类似研究结果相比,我们的结果是独特的。评估了本研究中发现的β地中海贫血突变频率,并与台湾北部和南部先前研究中发现的频率进行了比较。

相似文献

1
Molecular diagnosis of patients with beta-thalassemia major in central Taiwan by amplified created restriction site analysis.应用扩增产生限制性酶切位点分析对台湾中部重型β地中海贫血患者进行分子诊断。
J Hum Genet. 1998;43(4):237-41. doi: 10.1007/s100380050080.
2
Prenatal and molecular diagnosis of beta-thalassemia major in Taiwan by naturally and amplified created restriction sites.台湾地区通过自然和扩增产生的限制性酶切位点对重型β地中海贫血进行产前和分子诊断
Int J Hematol. 1993 Dec;59(1):1-8.
3
Molecular basis of beta-thalassemia minor in Taiwan.台湾地区轻型β地中海贫血的分子基础。
Int J Hematol. 1994 Jun;59(4):267-72.
4
Rapid detection of beta-Thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control.利用自然或扩增产生的限制性位点及直接测序技术快速检测埃及β地中海贫血等位基因:疾病防控的重要一步
Hemoglobin. 2007;31(1):49-62. doi: 10.1080/03630260601057088.
5
Molecular analysis of beta-thalassemia in South Vietnam.越南南部β地中海贫血的分子分析。
Am J Hematol. 2002 Oct;71(2):85-8. doi: 10.1002/ajh.10193.
6
Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.巴勒斯坦约旦河西岸地区地中海贫血患者中β-珠蛋白基因突变谱
Hemoglobin. 2005;29(2):119-32.
7
Molecular basis and haematological characterization of beta-thalassaemia major in Taiwan, with a mutation of IVS-1 3' end TAG-->GAG in a Chinese patient.台湾重型β地中海贫血的分子基础及血液学特征,一例中国患者存在IVS-1 3'端TAG→GAG突变
Br J Haematol. 1993 Jan;83(1):112-7. doi: 10.1111/j.1365-2141.1993.tb04640.x.
8
Spectrum of beta-thalassemia mutations and their association with allelic sequence polymorphisms at the beta-globin gene cluster in an Eastern Indian population.印度东部人群中β地中海贫血突变谱及其与β珠蛋白基因簇等位基因序列多态性的关联。
Am J Hematol. 2002 Aug;70(4):269-77. doi: 10.1002/ajh.10117.
9
Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients.利用聚合酶链反应-扩增阻滞突变系统和直接DNA测序技术对一组埃及地中海贫血患者进行β-地中海贫血突变研究。
Hemoglobin. 2007;31(1):63-9. doi: 10.1080/03630260601057104.
10
[Current clinical approaches and gene mutation study of beta-thalassemia major].[重型β地中海贫血的当前临床治疗方法及基因突变研究]
Gaoxiong Yi Xue Ke Xue Za Zhi. 1995 Feb;11(2):98-109.